Impact of Hepatitis C treatment on behavioural change in relation to drug use in people who inject drugs: A systematic review

被引:26
|
作者
Caven, Madeleine [1 ]
Malaguti, Amy [1 ,2 ,3 ,4 ]
Robinson, Emma [1 ,5 ]
Fletcher, Emma [1 ,2 ]
Dillon, John F. [1 ,5 ]
机构
[1] Univ Dundee, Sch Med, Dundee, Scotland
[2] Kings Cross Hosp, NHS Tayside, Publ Hlth Directorate, Dundee, Scotland
[3] Univ Dundee, Sch Social Sci Psychol, Dundee, Scotland
[4] NHS Tayside, Adult Psychol Therapies Serv, 15 Dudhope Terrace, Dundee, Scotland
[5] Ninewells Hosp, NHS Tayside, Dept Gastroenterol, Dundee, Scotland
关键词
Hepatitis C; People who inject drugs; Injecting risk behaviours; Behaviour change; Systematic review; VIRUS-INFECTION; RISK BEHAVIORS; HCV TREATMENT; PREVENTION; TRANSMISSION; MANAGEMENT;
D O I
10.1016/j.drugpo.2019.05.011
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: A systematic review was conducted to determine the impact of Hepatitis C (HCV) treatment on substance use behaviour in people who inject drugs (PWID). Methods: A search for peer reviewed journal articles from 1991 to present day was conducted using the following databases: PubMed, EMBASE, CINAHL and PsycINFO. Studies were appraised against the following inclusion criteria: recruitment of PWID for HCV treatment (either interferon alpha or direct acting antivirals based); measurement of behavioural change in relation to drug use; studies published in English. Results: Five studies investigating the impact of HCV treatment on behavioural change in relation to drug use amongst PWID were identified. Studies investigated the impact of HCV treatment on past month injecting drug use (four studies), injecting frequency (two studies), needle and syringe borrowing (two studies) and injecting equipment sharing (three studies). Three of the four studies assessing impact of treatment on past month injecting frequency found treatment significantly reduced the odds of participants reporting past month injecting at follow up. One study found that there was significant reduction in weekly injecting frequency between enrolment, treatment and follow up. No association was found between treatment engagement and needle and syringe borrowing. Two out of three studies reported a significant decrease in injecting equipment sharing between enrolment, treatment and follow up. Conclusions: Comparison and synthesis of results was challenging due to heterogeneity between studies. Moreover, four out of the five selected studies were conducted during the interferon era of treatment, possibly limiting the generalisability of the current review's results to the new DAA treatment era. However, it is likely that engaging in treatment has a positive impact upon patients' injecting drug use and injection equipment sharing behaviour. This raises the possibility that this may be an opportune time for further harm reduction measures.
引用
收藏
页码:169 / 176
页数:8
相关论文
共 50 条
  • [1] Behavioural interventions for preventing hepatitis C infection in people who inject drugs: A global systematic review
    Sacks-Davis, Rachel
    Horyniak, Danielle
    Grebely, Jason
    Hellard, Margaret
    [J]. INTERNATIONAL JOURNAL OF DRUG POLICY, 2012, 23 (03) : 176 - 184
  • [2] Hepatitis C Treatment in People Who Inject Drugs
    Benjamin Eckhardt
    [J]. Current Treatment Options in Infectious Diseases, 2016, 8 (4) : 416 - 425
  • [3] HIV and the criminalisation of drug use among people who inject drugs: a systematic review
    DeBeck, Kora
    Cheng, Tessa
    Montaner, Julio S.
    Beyrer, Chris
    Elliott, Richard
    Sherman, Susan
    Wood, Evan
    Baral, Stefan
    [J]. LANCET HIV, 2017, 4 (08): : E357 - E374
  • [4] The Impact of Injecting Networks on Hepatitis C Transmission and Treatment in People Who Inject Drugs
    Hellard, Margaret
    Rolls, David A.
    Sacks-Davis, Rachel
    Robins, Garry
    Pattison, Philippa
    Higgs, Peter
    Aitken, Campbell
    McBryde, Emma
    [J]. HEPATOLOGY, 2014, 60 (06) : 1861 - 1870
  • [5] THE IMPACT OF INJECTING NETWORKS ON HEPATITIS C TRANSMISSION AND TREATMENT IN PEOPLE WHO INJECT DRUGS
    Hellard, M.
    Rolls, D.
    Davis, R. Sacks
    Robins, G.
    Pattison, P.
    Higgs, P.
    Aitken, C.
    McBryde, E.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 : S23 - S24
  • [6] A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region
    Jeffrey V Lazarus
    Ida Sperle
    Mojca Maticic
    Lucas Wiessing
    [J]. BMC Infectious Diseases, 14
  • [7] A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region
    Lazarus, Jeffrey V.
    Sperle, Ida
    Maticic, Mojca
    Wiessing, Lucas
    [J]. BMC INFECTIOUS DISEASES, 2014, 14
  • [8] Promoting treatment for hepatitis C in people who inject drugs: A review of the barriers and opportunities
    Pedlar, Annie
    Sandhu, Prabjot
    [J]. JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2020, 32 (08) : 563 - 568
  • [9] Hepatitis C virus treatment as prevention in people who inject drugs
    White, Peter J.
    Abubakar, Ibrahim
    [J]. LANCET INFECTIOUS DISEASES, 2018, 18 (04): : 379 - 379
  • [10] Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs
    Rosenthal, Elana S.
    Silk, Rachel
    Mathur, Poonam
    Gross, Chloe
    Eyasu, Rahwa
    Nussdorf, Laura
    Hill, Kristi
    Brokus, Christopher
    D'Amore, Aaron
    Sidique, Nadeera
    Bijole, Phyllis
    Jones, Miriam
    Kier, Randy
    McCullough, Dana
    Sternberg, David
    Stafford, Kristen
    Sun, Junfeng
    Masur, Henry
    Kottilil, Shyamasundaran
    Kattakuzhy, Sarah
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (07) : 1715 - 1722